** Shares of cannabis firms fall as U.S. Drug Enforcement Administration $(DEA)$ judge on Monday cancelled marijuana rescheduling hearings
** Tilray Brands falls 1.5% and Cresco Labs down 3.8%
** Toronto-listed shares of Canopy Growth down 2%, Trulieve Cannabis falls 2.7% and Curaleaf Holdings
down 3.2%
** John Mulrooney, the DEA administrative law judge, cancelled the scheduled January 21 merit-based hearing and stayed the proceedings for at least three months
** Despite marijuana being legal in dozens of U.S. states, federal law categorizes it as a schedule I drug and prohibits most conventional U.S. banks from doing business with cannabis firms
(Reporting by Pooja Menon in Bengaluru)
((Pooja.Menon@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.